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1. INTRODUCTION 
3T3-L1 cells are a clone of Swiss/3T3 fibroblasts 
that spontaneously differentiate into adipocytes 
with a high frequency when in a resting state 
[1-4]. The differentiation process normally takes 
several weeks after the cells have become con- 
fluent, but it may be speeded up by treating the 
cells with the inducers l-methyl-3-isobutylxan- 
thine (MIX) and dexamethasone (Dex) [5] or 
others [2,3,6-8]. 
During differentiation of the adipocytes a num- 
ber of morphological and physiological changes 
occur. The 3T3-LI cells change from spindle- 
shaped fibroblast cells to larger, spherical cells and 
accumulate large triglyceride droplets [1-4]. Dur- 
ing differentiation almost all the enzymes involved 
in de novo fatty acid [6-10] and triacylglycerol [11] 
synthesis ncrease coordinately and the synthesis of 
>60 cellular proteins is greatly increased [12,13]. 
The differentiating cells acquire sensitivity to phys- 
iological concentrations of insulin via an increased 
number of receptors which have a higher binding 
capacity than preadipocyte insulin receptors [5]. 
The cells also acquire a catecholamine-sensitive 
adenylate cyclase system involved in the lipolytic 
response to catecholamines [14]. Poly(ADP)- 
ribosylation also changes during adipocyte con- 
version: the activity of poly(ADP-ribose) syn- 
thetase drops sharply upon the induction of dif- 
ferentiation by MIX, Dex and insulin, continues to 
decrease for several hours, and then, concurrently 
with the appearance of phenotypic expression, in- 
creases to a level higher than that in pre-adipo- 
cytes [15]. This transient reduction in poly(ADP)- 
ribosylation activity has been postulated as an early 
essential event in differentiation [15] which re- 
flects changes in chromatin structure [16,17]. In a 
separate study, involvement of poly(ADP-ribose) 
synthetase in insulin-stimulated cell growth has 
been suggested [ 18]. 
Here, we examined the effect of nicotinamide, 
which is known to be a strong inhibitor of poly- 
(ADP-ribose) synthetase [19,201, on the adipocyte 
differentiation of 3T3-L1 cells. Our results indi- 
cated that in fact nicotinamide inhibits differentia- 
tion and that this inhibition is correlated with the 
prevention of inducer-stimulated cell growth. 
Studies using nicotinamide analogues further sup- 
port the previous proposition [15] that poly(ADP)- 
ribosylation is crucial in triggering the adipocyte 
differentiation program. 
2. MATERIALS AND METHODS 
Dulbecco's modified Eagle's medium (DMEM), 
fetal calf serum (FCS), calf serum (CS), penicil- 
lin-streptomycin, sodium bicarbonate, and trypan 
blue were purchased from Grand Island Biological 
Co. (New York). Glutamine, nicotinamide and its 
analogues, l-methyl-3-isobutylxanthine (MIX), 
and dexamethasone (Dex) were purchased from 
Sigma (St Louis). 3T3-L1 cells were purchased 
from the American Type Culture Collection (Beth- 
esda). 
2.1. Tissue culture 
3T3-LI cells were routinely grown in DMEM 
supplemented with 10% CS, 2 mM glutamine, pen- 
icillin (100 units/ml), and streptomycin (100~g/ 
ml). Cultures were maintained at 37°C in a 95% 
air/5% CO2 atmosphere. 
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2.2. Differentiation 
3T3-L1 cells (1.5 × 105) were plated in 35 mm 
Petri dishes (Falcon) in 2 ml of either DMEM 
+ 10% CS (DMEMCS10) or DMEM + 10% FCS 
(DMEMFCS 10). Three days after the cells reached 
confluence the medium was replaced with fresh 
DMEMFCSI0 containing 0.5mM MIX and 
0.25 ~M Dex. Two days later the inducer-con- 
taining medium was replaced with fresh 
DMEMFCS10. Medium was changed every 3 days 
thereafter. The drugs were added at various times 
as described in section 3. 
2.3. Cell counting 
Cells were washed twice with Dulbecco's phos- 
phate-buffered saline containing 0.02% EDTA and 
detached by trypsinization at 37°C for 5-10 min. 
The numbers of live and dead cells were deter- 
mined by trypan blue staining. Adipocytes were 
identified by the presence of large lipid droplets 
and counted. Counting was done on a hemo- 
cytometer. 
3. RESULTS 
Since 15 mM nicotinamide significantly inhib- 
ited the differentiation of 3T3-L1 cells into adipo- 
cytes (not shown), various treatment periods with 
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Fig.1. Dose-dependent i hibition of adipocyte differen- 
tiation by nicotinamide. Confluent 3T3-L1 cells were 
treated with MIX and Dex for 2 days (0 d /+ 2 d) and 
with nicotinamide for 9 days (0 d /+9 d). Cells were 
counted on day 9. 
15 mM nicotinamide, in relation to the induction 
period, were tested. All of the treatment periods 
had some inhibitory effect on differentiation 
Table 1 
Effects of nicotinamide on adipocyte differentiation and growth of 3T3-L1 
cells 
Additives Periods Adipocyte Growth 
treated a differentiation 
% total Relative Cell no. Relative 
cells to B dish ( × 106) to A 
A. None - 0.0 - 1.4 1.00 
B. Inducers 0 d/+ 2 d 43.2 1.00 2.6 1.86 
C. Nam -2 d/ 0 d 22.6 0.52 2.0 1.43 
D. Nam -2d /+2d 7.4 0.17 1.6 1.14 
E. Nam 0 d/+ 2 d 10.5 0.24 1.7 1.21 
F. Nam + 2 d/+ 7 d 39.6 0.92 0.4 1.71 
a Inducers (MIX and Dex) were added during the period 0 d /+2 d and 
then removed, while nicotinamide (Nam) was present at 15 mM during 
the periods indicated 
Adipocyte differentiation and cell number were counted on day 7. Average 
of 2 determinations 
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(table 1). The period starting 2 days before the ad- 
dition of the inducers into growth-arrested 3T3-L1 
cells and continuing through the second day of in- 
duction ( -2  d /+ 2 d) was the most effective. A no- 
table exception was the nicotinamide treatment 
period that began when the inducers were re- 
moved on the second day and continued for 5 days 
( + 2 d /+ 7 d). In this case, nicotinamide no longer 
inhibited adipocyte differentiation. Table 1 also 
shows that the inducers (MIX and Dex) stimulate 
division in the 3T3-LI cells and that the inhibition 
of differentiation by nicotinamide is correlated 
with the prevention of the inducers' mitogenic 
effect. 
Next, the inhibition caused by various concen- 
trations of nicotinamide was investigated (fig.l). 
The confluent 3T3-LI cells were treated with MIX 
and Dex for 2 days (0 d /+ 2 d) and with nicotin- 
amide for 9 days (0 d /+ 9 d) and the cells counted 
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Fig.2. Time-course of adipocyte differentiation and cell 
growth with and without nicotinamide: (6) control cul- 
tures received neither nicotinamide (Nam) nor inducers; 
(.) Nam (-) cultures were treated with MIX and Dex 
for 2 days (0 d/+2 d); (o) Nam (+) cultures were treat- 
ed with 15 mM Nam according to the -2  d /+ 2 d treat- 
ment schedule described in table 1 and with MIX and 
Dex for 2 days (0 d/+ 2 d). Cell numbers are indicated 
with smaller symbols. 
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Fig.3. Effects of various nicotinamide analogues on 
adipocyte differentiation and growth of 3T3-LI ceils. 
One control culture (None) received neither drugs nor 
inducers and the other (Ind) received only MIX and 
Dex for 2 days (0 d/+ 2 d). Other cultures received, in 
addition to MIX and Dex for 2 days (0 d/+2 d), 5 mM, 
10raM and 15mM (left-right) of l-methylnicotin- 
amide (1-me-Nam), thymine (Thy), nicotinamide 
(Nam), N'-methylnicotinamide (N'-me-Nam), and 
benzamide (Bam) according to the -2 d/+2 d treat- 
ment schedule described in table 1. Percent adipocytes 
and cell number were determined on day 7. 
on day 9. Inhibition of differentiation by nicotin- 
amide was dose-dependent with an apparent EDso 
of 10 mM (fig.l). 
Fig.2 shows the time-course of 3T3-L1 cell 
growth and adipocyte differentiation after inducer 
treatment in the presence or absence of nicotin- 
amide. As in table 1, nicotinamide clearly inhib- 
ited both inducer-stimulated cell growth and dif- 
ferentiation. 
Finally, a number of analogues of nicotinamide 
were tested for the ability to inhibit 3T3-L1 dif- 
ferentiation into adipocytes (fig.3). Of the drugs 
tested at 3 different concentrations, benzamide was 
the most potent inhibitor. Following benzamide in 
potency was N'-methylnicotinamide, nicotinamide 
and thymine. 1-Methylnicotinamide was the least 
potent inhibitor of differentiation. Again, the inhi- 
bition of differentiation was correlated with the 
prevention of cell growth. 
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4. DISCUSSION 
These data show that nicotinamide and some of 
its analogues inhibit the differentiation of 3T3-LI 
preadipocytes into adipocytes. The mechanism(s) 
by which the inducers MIX and Dex facilitate 
adipocyte differentiation is not fully understood 
[5]. However, it is apparent hat growth-arrested 
3T3-L1 cells respond to these inducers and double 
the cell number before entering into adipocyte dif- 
ferentiation [5,6]. This mitogenic response of 3T3- 
LI cells to the inducers was suppressed by nicotin- 
amide and some of its analogues. It is known that 
MIX is an inhibitor of cyclic nucleotide phospho- 
diesterase and increases the intracellular cAMP 
level by preventing its degradation [7] and that 
Dex inhibits the biosynthesis of prostaglandin E1 
or its precursor or products [21]. Indirect evidence 
suggests that addition of prostaglandin El to 3T3 
cells increases the cAMP level and stimulates 
DNA synthesis and that this stimulation is syn- 
ergistically enhanced by the addition of MIX [8]. 
There is also evidence that addition of dibutyryl 
cAMP in 3T3-L1 culture enhances the rate of 
adipocyte differentiation [8]. At present, there is no 
unified model by which induction of adipocyte dif- 
ferentiation can be understood at the molecular 
level. Phenomenologically, in the absence of in- 
ducing conditions 3T3-L1 cells become arrested in 
a stage within G I phase. When inducers are add- 
ed, they go through one full cell cycle and become 
arrested at another state, from which they proceed 
to differentiate into adipocytes. These two states 
may be designated Gs and Gd, as proposed in [22], 
for 3T3 T pro-adipocytes, which are similar to 
3T3-L1 pre-adipocytes though not identical. Nic- 
otinamide inhibits differentiation apparently by 
preventing 3T3-LI cells from leaving the potenti- 
ated state and entering the differentiation pro- 
gram. 
Nicotinamide is a potent inhibitor of poly(ADP- 
ribose) synthetase in addition to being a precursor 
for new NAD + biosynthesis [16,17,19,20]. Poly- 
(ADP-ribose) synthetase catalyzes the formation of 
the ADP-ribose homopolymer f om NAD + and 
appears to have a regulatory role in cell prolifera- 
tion and differentiation [16,17]. As described in 
section 1, there is a transient decrease of poly- 
(ADP-ribose) synthetase activity and a subsequent 
increase during the initial period of adipocyte in- 
duction [15]. Since nicotinamide inhibited adipo- 
cyte differentiation and this inhibition was seen 
only if the drug was added before or concurrently 
with the inducers, the recovery of ADP-ribosyla- 
tion activity from the decreased state during the 
initial period of induction may be essential for 
adipocyte differentiation. The strong inhibition of 
differentiation by benzamide, which is also an in- 
hibitor of poly(ADP-ribose) synthetase [20], fur- 
ther indicates the involvement of this enzyme in 
regulating differentiation. Its involvement is fur- 
ther suggested by the observation that adipocyte 
differentiation is inhibited by N'-methylnicotin- 
amide which is not an inhibitor of poly(ADP- 
ribose) synthetase but is an inhibitor of NAD + 
synthesis [20]. In the presence of N'-methylnicotin- 
amide, the rise of poly(ADP)-ribosylation may be 
prevented ue to a lack of NAD +. Although the 
exact mechanisms remain to be elucidated, this 
work supports the proposal [15] that adipocyte dif- 
ferentiation i volves ADP-ribosylation. 
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